OPEN UP THE FUTURE Trademark

Trademark Overview


On Wednesday, April 20, 2016, a trademark application was filed for OPEN UP THE FUTURE with the United States Patent and Trademark Office. The USPTO has given the OPEN UP THE FUTURE trademark a serial number of 79190556. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by Mitsubishi Tanabe Pharma Corporation. The OPEN UP THE FUTURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical prepar...
open up the future

General Information


Serial Number79190556
Word MarkOPEN UP THE FUTURE
Filing DateWednesday, April 20, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158514
Registration DateTuesday, March 14, 2017
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMitsubishi Tanabe Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, August 25, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, August 31, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 26, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, August 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 29, 2016ASSIGNED TO EXAMINER
Tuesday, August 30, 2016NON-FINAL ACTION WRITTEN
Friday, September 16, 2016REFUSAL PROCESSED BY IB
Monday, October 31, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, August 31, 2016REFUSAL PROCESSED BY MPU
Wednesday, August 31, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 2, 2016APPLICATION FILING RECEIPT MAILED
Monday, October 31, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 2, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, November 2, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 2, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Friday, March 31, 2017LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, June 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 22, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 7, 2017LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, June 22, 2017FINAL DISPOSITION PROCESSED
Friday, July 14, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 29, 2023CANCELLED SECTION 71
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, June 27, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, July 20, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 27, 2024INVALIDATION PROCESSED
Thursday, November 8, 2018NEW REPRESENTATIVE AT IB RECEIVED